Jiangxi Fushine Pharmaceutical Co., Ltd. logo

Jiangxi Fushine Pharmaceutical Co., Ltd. (300497)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
19. 03
-0.02
-0.105%
¥
8.61B Market Cap
- P/E Ratio
0.8% Div Yield
29.84M Volume
- Eps
¥ 19.05
Previous Close
Add Transaction
Day Range
18.21 19.35
Year Range
9.4 24.18
Want to track 300497 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300497 trading today lower at ¥19.03, a decrease of -0.105% from yesterday's close, completing a monthly decrease of -12.7464% or -¥2.78. Over the past 12 months, 300497 stock gained 23.5714%.
300497 is not paying dividends to its shareholders.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0402%, based on the last three reports.
Jiangxi Fushine Pharmaceutical Co., Ltd. has completed 4 stock splits, with the recent split occurring on May 18, 2020.
The company's stock is traded on one exchange.

300497 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.89
0%
China Reform Health Management Co., Ltd.
¥ 7.52
-0.2653%
Acro Biosystems Co., Ltd.
¥ 81.88
+5.3797%
EIT Environmental Development Group Co., Ltd.
¥ 16.54
-1.0174%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Jiangxi Fushine Pharmaceutical Co., Ltd. (300497) FAQ

What is the stock price today?

The current price is ¥19.03.

On which exchange is it traded?

Jiangxi Fushine Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300497.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 8.61B.

Has Jiangxi Fushine Pharmaceutical Co., Ltd. ever had a stock split?

Jiangxi Fushine Pharmaceutical Co., Ltd. had 4 splits and the recent split was on May 18, 2020.

Jiangxi Fushine Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Jian Hua Bao CEO
XSHE Exchange
CNE1000024Z7 ISIN
CN Country
1,774 Employees
8 Jul 2021 Last Dividend
3 Jul 2018 Last Split
- IPO Date

Overview

Jiangxi Fushine Pharmaceutical Co., Ltd., founded in 2002 and headquartered in Jingdezhen, China, is a prominent player in the pharmaceutical sector with a global presence. The company is dedicated to the research, development, manufacture, and sale of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Initially established as Jingdezhen Fuxiang Pharmaceutical Co., Ltd, it underwent a name change to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012 to better reflect its expanding capabilities and strategic direction. Fushine also offers a broad range of contract services, spanning research, development, and manufacturing, indicating its versatility in the pharmaceutical industry. Moreover, the company has ventured into providing additives for lithium battery electrolytes, showcasing its adaptability and innovation in meeting the diverse needs of its customers both in China and internationally.

Products and Services

  • Penicillin

    As one of its key products, Jiangxi Fushine Pharmaceutical Co., Ltd. specializes in the production of various penicillin-based antibiotics. These antibiotics are essential in fighting a wide array of bacterial infections, reinforcing the company's role in supporting global healthcare efforts.

  • Carbapenem

    Fushine produces carbapenems, a class of highly effective antibiotics used to treat severe or high-risk bacterial infections. This underscores the company's commitment to addressing critical healthcare challenges and providing solutions for hard-to-treat conditions.

  • Antiviral Drug Intermediates

    The company also manufactures intermediates for antiviral drugs, playing a crucial role in the supply chain for medications that are instrumental in the fight against viral epidemics and pandemics.

  • Contract Research, Development, and Manufacturing Services

    Fushine provides comprehensive contract services encompassing research, development, and manufacturing for partners across the globe. These services enable clients to leverage Fushine's expertise in pharmaceutical development and manufacturing, ensuring high-quality outcomes and efficiency in bringing products to market.

  • Lithium Battery Electrolyte Additives

    Expanding beyond its pharmaceutical roots, Jiangxi Fushine Pharmaceutical Co., Ltd. has ventured into the production of additives for lithium battery electrolytes. This diversification exemplifies the company’s innovation and its ability to adapt its research and manufacturing capabilities beyond the bounds of the traditional pharmaceutical industry, catering to the growing demand in the energy sector.

Contact Information

Address: No. 2, Yuli Industrial Zone, Jingdezhen, China, 333000
Phone: 86 79 8269 9929